BVS·09075A108·US·equity·Healthcare - Medical Devices-13D/G
BVS (BIOVENTUS INC A) is held by 88 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($28.6M), ROYCE & ASSOCIATES LP ($14.1M), GEODE CAPITAL MANAGEMENT, LLC ($10.7M). Net institutional sentiment: Mixed.
See how BVS's score breaks down across 4 SEC sources
Showing 1-20 of 96
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer